Goldman Sachs MLP and Energy Renassnc Fd (GER) Insider Matthew Cooper Buys 20,250 Shares

Share on StockTwits

Goldman Sachs MLP and Energy Renassnc Fd (NYSE:GER) insider Matthew Cooper bought 20,250 shares of the company’s stock in a transaction dated Tuesday, May 14th. The stock was bought at an average price of $5.62 per share, with a total value of $113,805.00. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website.

Shares of Goldman Sachs MLP and Energy Renassnc Fd stock traded up $0.04 on Thursday, reaching $5.68. The company had a trading volume of 3,927 shares, compared to its average volume of 320,052. Goldman Sachs MLP and Energy Renassnc Fd has a 1 year low of $3.88 and a 1 year high of $7.13.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 29th. Stockholders of record on Tuesday, May 21st will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 11.27%. The ex-dividend date is Monday, May 20th.

Several hedge funds have recently modified their holdings of the stock. Advisor Group Inc. lifted its stake in shares of Goldman Sachs MLP and Energy Renassnc Fd by 22.3% during the 1st quarter. Advisor Group Inc. now owns 14,463 shares of the investment management company’s stock worth $81,000 after acquiring an additional 2,638 shares during the last quarter. Raymond James Financial Services Advisors Inc. lifted its stake in shares of Goldman Sachs MLP and Energy Renassnc Fd by 3.4% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 138,822 shares of the investment management company’s stock worth $768,000 after acquiring an additional 4,589 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. lifted its stake in shares of Goldman Sachs MLP and Energy Renassnc Fd by 5.8% during the 1st quarter. Ladenburg Thalmann Financial Services Inc. now owns 111,259 shares of the investment management company’s stock worth $615,000 after acquiring an additional 6,134 shares during the last quarter. Golden State Wealth Management LLC bought a new stake in shares of Goldman Sachs MLP and Energy Renassnc Fd during the 1st quarter worth approximately $35,000. Finally, Madrona Financial Services LLC bought a new stake in shares of Goldman Sachs MLP and Energy Renassnc Fd during the 4th quarter worth approximately $62,000.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4343318/goldman-sachs-mlp-and-energy-renassnc-fd-ger-insider-matthew-cooper-buys-20250-shares.html.

About Goldman Sachs MLP and Energy Renassnc Fd

Goldman Sachs MLP and Energy Renaissance Fund is a closed-ended equity mutual fund launched and managed by Goldman Sachs Asset Management, L.P. The fund invests in public equity markets of the United States. It seeks to invest in stocks of companies operating in the energy sector. The fund primarily invests in growth stocks of Master Limited Partnerships and related energy companies across all market capitalizations, with a focus on midstream MLP investments.

Further Reading: What is Depreciation?

Receive News & Ratings for Goldman Sachs MLP and Energy Renassnc Fd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Goldman Sachs MLP and Energy Renassnc Fd and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Paragon Banking Group’s  Hold Rating Reiterated at Numis Securities
Paragon Banking Group’s Hold Rating Reiterated at Numis Securities
Short Interest in Moleculin Biotech Inc  Grows By 327.4%
Short Interest in Moleculin Biotech Inc Grows By 327.4%
OrganiGram  Sets New 52-Week High at $11.30
OrganiGram Sets New 52-Week High at $11.30
Weekly Analysts’ Ratings Changes for Seres Therapeutics
Weekly Analysts’ Ratings Changes for Seres Therapeutics
Liberum Capital Reiterates “Hold” Rating for Bovis Homes Group
Liberum Capital Reiterates “Hold” Rating for Bovis Homes Group
Fresenius SE & Co KGaA  Given a €50.00 Price Target at Morgan Stanley
Fresenius SE & Co KGaA Given a €50.00 Price Target at Morgan Stanley


© 2006-2019 Ticker Report